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tion of mutant Ataxin 1 protein is 
delayed until after postnatal day 14, 
it would appear that Purkinje cell 
neurons are much better equipped 
to tolerate exposure to toxic mis-
folded proteins. It is very intriguing 
that the window is so narrow, as the 
presented data suggest that large 
amounts of Ataxin 1 protein do not 
appear until postnatal day 10. None-
theless, the presence of mutant pro-
tein for scarcely 5 days is sufficient 
to elicit this profound toxic effect. In 
the polyQ repeat diseases HD and 
SBMA, it has been proposed that 
the normal function of the disease 
protein is required for preventing or 
retarding progression of the degen-
erative phenotype (Cattaneo et al., 
2005; Thomas et al., 2006). As both 
the huntingtin protein and the andro-
gen receptor protein appear impor-
tant for neurons during develop-
ment, diminished normal function of 
these proteins due to polyQ expan-
sions during development could 
place adult neurons at heightened 
risk of degeneration when forced to 
deal with polyQ gain-of-function tox-
icity. For these reasons, defining the 
normal functions and interactions of 
dominant disease proteins may shed 
light upon processes of neurodegen-
eration and, perhaps, even pathways 
of cell type specificity in the CNS.
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Synaptic vesicles mediate the release of neurotransmitters at nerve terminals. In this issue 
of Cell, Takamori et al. (2006) analyze the lipid and protein components of synaptic vesicles, 
providing the most comprehensive description of synaptic vesicles to date.At synapses, neurotransmission is 
mediated by exocytosis of synap-
tic vesicles that are filled with neu-
rotransmitters (Katz, 1969). Synaptic 
vesicles occupy the presynaptic ter-
minal and are unusually abundant, 
so much so that the brain could be 
considered a micromolar solution of 
synaptic vesicles. Because of their 
abundance and uniform size, syn-
aptic vesicles are easy to purify and characterize, which has made them 
among the best characterized organ-
elles in biology. From their initial 
description, synaptic vesicles have 
been viewed as a model organelle 
that could be used to elucidate gen-
eral principles of membrane traffic 
(Südhof and Jahn, 1991). This prom-
ise was realized early on with the dis-
covery of SNARE proteins that medi-
ate membrane fusion events, and of Cell 127, Novsynaptotagmins that control the trig-
gering of fusion by Ca2+. The paper 
presented in this issue by Takamori 
et al. (2006) now reports a complete 
quantitative description of the pro-
tein and lipid composition of synaptic 
vesicles, thereby confirming the stat-
ure of synaptic vesicles as a model 
organelle.
Previous work had already largely 
characterized the overall protein and ember 17, 2006 ©2006 Elsevier Inc. 671
lipid composition of synaptic vesicles 
but did not provide insight into the quan-
titative relations among these compo-
nents (reviewed in Südhof, 2004). In a 
technical tour de force, Takamori et al. 
(2006) now employ a combination of 
biophysical and proteomic approaches 
to address this issue, culminating in the 
construction of the first atomic model 
for any organelle. Among the surprising 
findings is the observation that a few 
proteins are very abundant in synaptic 
vesicles, accounting for the majority of 
their proteins. These include synapto-
brevin 2/VAMP2, with approximately 
70 copies per vesicle; synaptophysin 1, 
with 30 copies per vesicle; and synap-
totagmin 1, with 15 copies per vesicle. In 
contrast, many proteins are present in 
only a few copies per vesicle. The most 
prominent example is the proton pump 
that is present as a single copy per ves-
icle (as originally shown by Stadler and 
Tsukita [1984]). However, because of 
its large size, the proton pump never-
theless accounts for more than 10% of 
the vesicle protein. In addition, calcu-
lation of the relative occupancy of the 
vesicle membrane by lipids and protein 
transmembrane regions suggests that 
approximately 20% of the membrane is 
occupied by transmembrane regions. 
This percentage is astonishingly high. 
Given that each transmembrane region 
is presumably surrounded by a ring of 
fixed phospholipids, this finding implies 
that there is very little fluid phospho-
lipid membrane present in synaptic 
vesicles. Thus, protein components 
dominate this fascinating organelle, 
making its membrane more rigid than 
anticipated.
The Takamori et al. (2006) study is 
the first to define the overall structure 
of an organelle in quantitative terms 
and has several important implica-
tions. The results confirm and extend 
previous studies demonstrating that 
a surprisingly high number of SNARE 
and Rab proteins are present on syn-
aptic vesicles (see Fischer von Mol-
lard et al., 1994; Walch-Solimena et 
al., 1995; Antonin et al., 2000). This 
finding not only partly explains why 
deletion of the SNARE protein synap-
tobrevin—although abolishing most 
exocytosis—does not completely 
block exocytosis (Schoch et al., 2001) 672 Cell 127, November 17, 2006 ©2006but, more importantly, also supports 
the notion that synaptic vesicles must 
participate in more membrane traf-
ficking reactions than just exo- and 
endocytosis. For example, the pres-
ence in synaptic vesicles of Rab and 
SNARE proteins, such as Rab5 and 
Vti1b, which are involved in endo-
somal fusion reactions, demonstrates 
that the vesicles must undertake 
occasional excursions to endosomes 
during their cycles of exo- and endo-
cytosis. These excursions may serve 
to “proofread” the composition of the 
vesicles and to sort out unwanted 
and/or damaged vesicle components. 
Moreover, the presence of multiple 
SNARE proteins involved in different 
types of fusion reactions suggests 
that synaptic vesicles are able to keep 
the various SNARE proteins apart by 
a specific mechanism and to use only 
the correct ones for a given traffick-
ing reaction. As an aside, this finding 
provides additional evidence that the 
specificity of membrane traffic can-
not be encoded by the SNARE pro-
teins themselves but must be medi-
ated at least in part by the regulators 
of SNARE proteins in the synapse, 
such as the membrane fusion pro-
tein Munc-18-1 (Hata et al., 1993). In 
addition, the fact that only a single 
copy of the proton pump is present 
argues against a second function of 
its subunits in membrane fusion in 
addition to its well-established role in 
the acidification of synaptic vesicles 
that is required for the loading of neu-
rotransmitter (Hiesinger et al., 2005). 
This is because it is difficult to imagine 
how 70 copies of the SNARE protein 
synaptobrevin/VAMP on the vesicle 
would act in fusion on a single proton 
pump in the cramped space of the 
vesicle/plasma membrane interface.
Like any important study, the Taka-
mori et al. (2006) paper raises a num-
ber of questions. A general question 
is, what determines the identity of 
an organelle, and when can we tell 
whether a protein is a true compo-
nent of that organelle (as opposed to a 
contaminant)? For those proteins that 
are not as abundant as SNARE pro-
teins or synaptophysin, localization is 
not sufficient to answer this question, 
and a functional definition of the pro- Elsevier Inc.tein is needed before a protein can be 
considered to be a true vesicle com-
ponent. In the same vein, what is the 
significance of multiple SNARE and 
Rab proteins on synaptic vesicles? 
As noted above, this finding confirms 
a participation of synaptic vesicles in 
endosomal trafficking in addition to 
exo- and endocytosis. However, some 
of the SNARE and Rab proteins on the 
vesicles, such as Rab7, are not known 
to participate in either plasma mem-
brane or endosomal fusion reactions, 
suggesting that synaptic vesicles 
may be more complex than currently 
envisioned and may participate in 
additional, as yet unknown, traffick-
ing reactions—for example, reactions 
involving lysosomes.
A third and equally important ques-
tion is how synaptic vesicles in differ-
ent types of synapses differ from each 
other. Significant functional and struc-
tural evidence indicates that vesicles 
are not identical. For example, GAB-
Aergic and glutamatergic vesicles 
exhibit distinct shapes in electron 
micrographs (Gray, 1959), indicat-
ing that these vesicles must differ in 
composition beyond their content. Do 
synaptic vesicles exhibit microhetero-
geneity—for example, in the number 
of synaptobrevin copies per vesicle or 
the presence of peripheral proteins, 
which may affect the probability of 
vesicle release? This would explain 
the observation that the release prob-
ability of vesicles is heterogeneous. 
Moreover, how do synaptic vesicles 
differ from other secretory organelles 
that are subject to Ca2+-triggered exo-
cytosis? The quantitative description 
of the composition of an average syn-
aptic vesicle is a pioneering achieve-
ment that sets the stage for creating 
an equally complete functional defini-
tion of the components and for under-
standing their diversity. This endeavor 
is underway and will be greatly aided 
by the establishment of synaptic ves-
icles as a reference organelle. More-
over, several findings by Takamori 
et al. (2006) may be applicable to all 
organelles and membrane structures, 
thereby forming the basis for future 
studies on how such organelles and 
membranes are constructed and how 
they function.
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(1993). Nature 366, 347–351.Protein folding in cells is facilitated by 
several elegant chaperone machines 
that improve folding efficiency and 
minimize the occurrence of mis-
folded proteins in a crowded macro-
molecular environment. The central 
components of these machines are 
finely tuned by regulators, or cochap-
erones, that balance the kinetic and 
thermodynamic constraints of client 
proteins and thus create an environ-
ment (termed folding solvent) to opti-
mize correct folding (Kelly and Balch, 
2006). Many components of this sys-
tem also recognize misfolded pro-
teins and facilitate their degradation 
through the ubiquitin proteasome sys-
tem. These competing pathways for 
protein maturation and degradation 
intersect in the endoplasmic reticulum 
(ER), where nearly a third of the cel-
lular proteome is synthesized, folded, 
and packaged for transport (Younger 
et al., 2006). In this issue, Wang et al., 
(2006) provide new insight into the 
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complexity of protein networks that 
populate the secretory pathway. They 
identify new factors that govern the 
fate of the cystic fibrosis transmem-
brane conductance regulator (CFTR), 
an apical membrane ATP-regulated 
chloride channel whose misfolding is 
implicated in cystic fibrosis.
Cystic fibrosis is an inherited dis-
ease of epithelial tissues caused 
primarily by point mutations that 
disrupt CFTR folding and delivery to 
the plasma membrane (Cheng et al., 
1990). CFTR folding takes place in the 
ER and requires the precise organiza-
tion of two transmembrane domains 
and three cytosolic domains prior to 
export (Xiong et al., 1997). In most 
cells, this process is both complex 
and inefficient (ure 1). Degradation 
approaches 100% for the major dis-
ease-related mutant, ∆F508, which is 
found in more than 90% of individu-
als with cystic fibrosis. Once folded, 
however, ∆F508 CFTR can traffic to 
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the plasma membrane and partially 
restore chloride transport. Thus, 
interventions that could restore ∆F508 
folding are of major clinical interest.
Wang et al., (2006) now address 
this problem using multidimensional 
protein identification technology 
(MudPIT) to identify nearly 200 pro-
teins (the “interactome”) from four 
different cell types that coimmuno-
precipitate with either wild-type or 
∆F508 CFTR. Some of these interac-
tions were either known or predicted 
based on prior studies of CFTR sta-
bility, trafficking, and endocytosis. 
However, the largest group—more 
than two-thirds of the proteins identi-
fied—have no known function related 
to CFTR. Even though some known 
interactions were not identified in 
this screen, which indicates that the 
total interactome is not yet complete, 
these data provide a valuable start-
ing point for further study. Notably, 
the presence of several elaborate 
e fold
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